FREE Account Opening + No Clearing Fees

Naturo Indiabull BSE SME IPO review (Avoid)

Review By Dilip Davda on August 16, 2022

•    NIL that was originally incorporated for IT-related services/products.
•    It changed its name and business model for the food business. 
•    It has posted average financial performance so far. 
•    Hefty premium collected for further equity issues/conversion boosted its NAV.
•    The issue is priced greedily, there is no harm in ignoring it. 

Of late we are witnessing fancy names for IPO-bound companies that are trying to lure investors with such names. They have no connection whatsoever with the name used. Recently we have seen Olatech IPO with "OLA" in its name. Now we have Naturo Indiabull with "INDIABULL" in its name. Both these companies have no connections with the brands or the group. Investors should not get carried away with such tactics. 

Naturo Indiabull Ltd. (NIL) erstwhile known as IT Indiabull Pvt. Ltd. was originally promoted for IT-related services but now it has entered into food processing with the change in name to the current one. It is in a highly competitive and fragmented segment. 

NIL was incorporated in the year 2016 and is into the business of Fast-Moving Consumer Goods (FMCG). At the time of incorporation, the main object was to carry on the business of software designing, development, customization, implementation, maintenance, testing, benchmarking, designing, developing, and dealing in computer software and solutions and to develop, provide, undertake, design, import, export, distribute and deal in systems and application software for microprocessor-based information system, offshore software development projects, BPO services, internet service provider, e-trading, website application solutions software enterprise, resource planning, e-commerce, value-added products, and other business applications.

However, from November 2019, it changed its object clause to carry on the business of garments, textiles, jewelry, FMCG, Real Estate, Stone-Mines, Herbal Products, Automobile, Printing, Share Trading, providing education, Agriculture Seeds and Fertilizers, Hospitality and Food items through Directly and/or through the network of members, consultants, bonafide commission agents, franchises, associates and distributors of multi-level marketing through network publicity, market research analysis, surveys, organizing events, contest, seminar and other advertising and related outdoor activities, as it found that to be more advantageous and profitable.

The Company is in the business of trading various health products and kits including Sanitary Towels, Sanitary Napkins, hand sanitizer, other health kits, etc. Now the Company is diversifying its products to various health and herbal products like juices, soaps, shampoos, medicines, tablets, etc. under the name and style of Naturo Indiabull Limited. The Company has started the distribution of Samples. It purchases the goods from various manufacturers and sells them in its own brand both directly to wholesalers and also through agents. Its areas of operations currently are Jaipur, Rajasthan. As of the date of filing this offer documents, it had 9 employees on its payroll. 

The company is currently dependent on third-party supply and is also liable to frequently changing government policies. 

To part finance its needs for working capital (Rs. 9.57 cr.), general corporate purposes (Rs. 1.00 cr.), NIL is coming out with a maiden IPO of 3640000 equity shares of Rs. 10 each at a fixed price of Rs. 30 per share to mobilize Rs. 10.92 cr. The issue opens for subscription on August 22, 2022, and will close on August 24, 2022. Minimum application is to be made for 4000 shares and in multiples thereon, thereafter. Post allotment, shares will be listed on BSE SME. The issue constitutes 35.69% of the post-IPO paid-up capital of the company. NIL is spending Rs. 0.35 cr. for this IPO process. 

The issue is solely lead-managed by Finshore Management Services Ltd., Link Intime India Pvt. Ltd. is the registrar to the issue.  Nikunj Stock Brokers Ltd. is a market maker for this IPO. 

Having raised initial equity at par and the company has issued/converted further equity in the price range of Rs. 260 - Rs. 290 per share between December 2020 and February 22. It has also issued bonus shares in the ratio of 15 for 1 in February 2022. The average cost of acquisition of shares by the promoters is Rs. 8.86 and Rs. 17.31 per share. 

Post-IPO, NIL's current paid-up equity capital of Rs. 6.56 cr. will stand enhanced to Rs. 10.20 cr. Based on the IPO pricing, the company is looking for a market cap of Rs. 30.59 cr. 

On the financial performance front, for the last three fiscals, NIL has posted turnover/net profits of Rs. 8.02 cr. / Rs. 0.79 cr. (FY20), Rs. 7.01 cr. / Rs. 0.75 cr. (FY21) and Rs. 11.45 cr. / Rs. 1.09 cr. (FY22). It has shown inconsistency in its top and bottom lines. 

For the last three fiscals, NIL has reported an average EPS of Rs. 3.16 and an average RoNW of 25.01%. The issue is priced at a P/BV of 1.55 based on its NAV of Rs. 19.30 as of March 2022 but the offer documents are silent on its post-IPO NAV details. Thanks to hefty premiums collected on conversion and further issuance of equity shares that boosted its NAV as of March 31, 2022.  

If we attribute FY22 higher earnings on post IPO fully diluted paid-up equity capital, then the asking price is at a P/E of around 28.03 making it a greedily priced IPO with concern over the sustainability of margins reported. 

As per the offer document, NIL has no listed peers to compare with.  

The company has not declared any dividends for the reported periods of offer documents. It will adopt a prudent dividend policy post-listing based on its financial performance and future prospects. 

This is the 28th mandate from Finshore Management in the last five fiscals (including the ongoing one). Out of the last 10 listings, 1 opened at discount, 2 at par, and the rest with premiums ranging from 0.9% to 150% on the day of listings. Thus it has an average track record.

Conclusion / Investment Strategy

The company has fared averagely in the last three fiscals after changing its business line. However, it has nothing to do with the Indiabull group. Even with the boosted profits for FY22, its IPO is greedily priced. There is no harm in ignoring this high-priced bet.

Reviewer recommends Avoid to the issue.

Review By Dilip Davda on August 16, 2022

Review Author

DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. My reviews do not cover GMP market and operators game plans. Readers must consult a qualified financial advisor before making any actual investment decisions, based the on information published here. With entry barriers, SEBI wants only well-informed investors to participate in such offers. With crazy listings in the recent past, SME IPOs drew the attention of investors across the board and lead to seer madness. However, as SME issues have entry barriers and continued low preference from the broking community, any reader taking decisions based on any information published here does so entirely at their own risk. The above information is based on information available as of date coupled with market perceptions. The Author has no plans to invest in this offer.

About Dilip Davda

Dilip Davda

Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.

Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detail fundamental and financial analysis of companies coming up with IPO helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.

(Dilip Davda -SEBI registered Research Analyst-Mumbai,

Registration no. INH000003127 (Perpetual)

Email id: ).

Naturo Indiabull IPO FAQs

  1. 1. Why Naturo Indiabull IPO?

    The initial public offer (IPO) of Naturo Indiabull Limited offers an early investment opportunity in Naturo Indiabull Limited. A stock market investor can buy Naturo Indiabull IPO shares by applying in IPO before Naturo Indiabull Limited shares get listed at the stock exchanges. An investor could invest in Naturo Indiabull IPO for short term listing gain or a long term.

  2. 2. How is Naturo Indiabull IPO?

    Read the Naturo Indiabull IPO recommendations by the leading analyst and leading stock brokers.

  3. 3. Naturo Indiabull IPO what should investors do?

    Naturo Indiabull IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges. Read the Naturo Indiabull IPO Notes, Analysis and Recommendations by leading stock brokerage firms and experts in the above answer.

  4. 4. Is Naturo Indiabull IPO good?

    Our recommendation for Naturo Indiabull IPO is to avoid.

  5. 5. Is Naturo Indiabull IPO worth Investing?

    As per the analysis by our lead analyst Mr. Dilip Davda, we suggest you to avoid the Naturo Indiabull IPO.

  6. 6. When will Naturo Indiabull IPO allotment status?

    The Naturo Indiabull IPO allotment status will be available on or around August 29, 2022. The allotted shares will be credited in demat account by September 1, 2022. Visit Naturo Indiabull IPO allotment status to check.

  7. 7. When will Naturo Indiabull IPO list?

    The Naturo Indiabull IPO will list on Friday, September 2, 2022, at BSE SME.